|
|
||||||||
From the Unitat de Biologia Cel.lular i Molecular (Drs. Tora, de Bolos, and Real), Institut Municipal d'Investigacio Medica, Universitat Autonoma de Barcelona, Barcelona, Spain; and the Servei de Neurologia (Dr. Graus), Hospital Clinic i Provincial, Universitat de Barcelona, Barcelona, Spain.
Supported in part by grant 92/0010 from Fondo de Investigaciones Sanitarias and grant GRQ93-9301 from CIRIT, Generalitat de Catalunya.
Received June 6, 1996. Accepted in final form August 27, 1996.
Address correspondence and reprint requests to Dr. Francisco X. Real, Institut Municipal d'Investigacio Medica, Carrer del Dr. Aiguader 80, 08003-Barcelona (Spain).
Article abstract-Background: Serum from patients with small-cell lung cancer-associated paraneoplastic encephalomyelitis/sensory neuronopathy contains autoantibodies recognizing 35- to 40-kDa nuclear antigens present in neurons, small-cell lung cancers, and some neuroblastomas (anti-Hu). Aim: Because the mechanisms by which Hu autoantibodies may contribute to the paraneoplastic syndrome are largely unknown, we sought to examine if Hu antigens are expressed at the plasma membrane of cultured cells from Hu-expressing tumors. Methods and results: Hu-related molecules of 35 to 41 kDa were detected in the membrane of small-cell lung cancers and neuroblastomas using: (1) immunofluorescence, (2) absorption assays, (3) Western blotting on membrane fractions, and (4) surface biotinylation. The antibodies recognizing these membrane components were specifically absorbed by recombinant HuD protein. There was a perfect correlation between nuclear and membrane Hu expression. To determine the purity of the subcellular fractions, their reactivity with antibodies recognizing the A2 nuclear ribonucleoprotein and the cytoplasmic mitogen-activated protein kinase was examined. None of them was detected in the membrane fractions reactive with sera containing Hu antibodies. Conclusions: Hu-related antigens can be detected both in the nucleus and the membrane of small-cell lung cancer and neuroblastomas. Implications: These results provide an experimental basis for surface binding-mediated pathogenic mechanisms in paraneoplastic encephalomyelitis/sensory neuronopathy and in Hu-expressing tumors.
NEUROLOGY 1997;48: 735-741
This article has been cited by other articles:
![]() |
H. Pellkofer, A. S. Schubart, R. Hoftberger, N. Schutze, M. Pagany, M. Schuller, H. Lassmann, R. Hohlfeld, R. Voltz, and C. Linington Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat Brain, August 1, 2004; 127(8): 1822 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.E. Monstad, L. Drivsholm, A. Storstein, J.H. Aarseth, M. Haugen, B. Lang, A. Vincent, and C.A. Vedeler Hu and Voltage-Gated Calcium Channel (VGCC) Antibodies Related to the Prognosis of Small-Cell Lung Cancer J. Clin. Oncol., March 1, 2004; 22(5): 795 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ohwada, I. Nagaoka, F. Takahashi, S. Tominaga, and Y. Fukuchi DNA Vaccination against HuD Antigen Elicits Antitumor Activity in a Small-Cell Lung Cancer Murine Model Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 37 - 43. [Abstract] [Full Text] |
||||
![]() |
R D VOLTZ, J B POSNER, J DALMAU, J B POSNER, J DALMAU, and F GRAUS Paraneoplastic encephalomyelitis: an update of the effects of the anti-Hu immune response on the nervous system and tumour J. Neurol. Neurosurg. Psychiatry, August 1, 1997; 63(2): 133 - 136. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |